Evidence map›Paper›PMID 38584749›Full record

ArticleThe Journal of innovations in cardiac rhythm management2024

Impact of Sarcoidosis on In-hospital Outcomes Among Patients with Atrial Fibrillation: A Nationwide Readmissions Database Analysis.

Min Choon Tan, Qi Xuan Ang, Yong Hao Yeo, Boon Jian San, Ramzi Ibrahim, Sze Jia Ng, Jian Liang Tan, Jasjit Walia, Addi Suleiman, Joaquim Correia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of innovations in cardiac rhythm management, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Min Choon TanDepartment of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, NJ, USA.
Qi Xuan AngDepartment of Internal Medicine, Sparrow Health System and Michigan State University, East Lansing, MI, USA.
Yong Hao YeoDepartment of Internal Medicine/Pediatrics, Beaumont Health, Royal Oak, MI, USA.
Boon Jian SanAIMST University, Bedong, Malaysia.
Ramzi IbrahimDepartment of Internal Medicine, University of Arizona-Banner University Medical Center, Tucson, AZ, USA.
Sze Jia NgDepartment of Internal Medicine, Crozer-Chester Medical Center, Upland, PA, USA.
Jian Liang TanDepartment of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Jasjit WaliaDepartment of Cardiovascular Medicine, New York Medical College at Saint Michael's Medical Center, Newark, NJ, USA.
Addi SuleimanDepartment of Cardiovascular Medicine, New York Medical College at Saint Michael's Medical Center, Newark, NJ, USA.
Joaquim CorreiaDepartment of Cardiovascular Medicine, New York Medical College at Saint Michael's Medical Center, Newark, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcoidosis is a disease that involves multiple organs, including the cardiovascular system. While cardiac sarcoidosis has been increasingly recognized, the impact of sarcoidosis on atrial fibrillation (AF) is not well established. This study aimed to analyze the impact of sarcoidosis on in-hospital outcomes among patients who were admitted for a primary diagnosis of AF. Using the all-payer, nationally representative Nationwide Readmissions Database, our study included patients aged ≥18 years who were admitted for AF between 2017-2020. We stratified the cohort into two groups depending on the presence of sarcoidosis diagnosis. The in-hospital outcomes were assessed between the two groups via propensity score analysis. A total of 1031 (0.27%) AF patients with sarcoidosis and 387,380 (99.73%) AF patients without sarcoidosis were identified in our analysis. Our propensity score analysis of 1031 (50%) patients with AF and sarcoidosis and 1031 (50%) patients with AF but without sarcoidosis revealed comparable outcomes in early mortality (1.55% vs. 1.55%,

Indexed as

Atrial fibrillationhospital outcomessarcoidosis

Identifiers

PMID38584749
PMCPMC10994093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.